Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers

Documenti analoghi

• Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers
  di: Tré-Hardy, Marie, et al.
  Pubblicazione: (2021)
• Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital
  di: Blairon, Laurent, et al.
  Pubblicazione: (2020)
• Efficacy comparison of three rapid antigen tests for SARS‐CoV‐2 and how viral load impact their performance
  di: Blairon, Laurent, et al.
  Pubblicazione: (2021)
• The challenge of screening SARS-CoV-2 variants of concern with RT-qPCR: One variant can hide another
  di: Blairon, Laurent, et al.
  Pubblicazione: (2021)
• The role of serology for COVID-19 control: Population, kinetics and test performance do matter
  di: Tré-Hardy, Marie, et al.
  Pubblicazione: (2020)